The Role of Amphiphilic Compounds in Nasal Nanoparticles
Nasal medications hold significant importance and are widely utilized due to their numerous advantageous properties, offering a compelling route for both local and systemic therapeutic effects. Nowadays, the development of nasal particles under 1 micrometer is in the focus of much scientific researc...
Gespeichert in:
Veröffentlicht in: | AAPS PharmSciTech 2024-11, Vol.25 (8), p.269, Article 269 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 8 |
container_start_page | 269 |
container_title | AAPS PharmSciTech |
container_volume | 25 |
creator | Quoc, Thinh To Bíró, Krisztina Pető, Ágota Kósa, Dóra Haimhoffer, Ádám Lekli, István Pallér, Ádám Bak, István Gyöngyösi, Alexandra Fehér, Pálma Bácskay, Ildikó Ujhelyi, Zoltán |
description | Nasal medications hold significant importance and are widely utilized due to their numerous advantageous properties, offering a compelling route for both local and systemic therapeutic effects. Nowadays, the development of nasal particles under 1 micrometer is in the focus of much scientific research. In our experiments, the use of innovative nanotechnology to increase the effectiveness of the active substance was of paramount importance. Our aim was to create solid nanoparticles that enable targeted and effective delivery of the active ingredient into the body. The innovation of this experimental series lies not only in highlighting the importance of amphiphilic compounds in enhancing penetration, but also in the fact that while most nasally administered formulations are in liquid form, our formulation is solid. Liquid formulations frequently suffer from the disadvantage of possible leakage during administration, which can reduce the bioavailability of the active ingredient. In our experiments we created novel drug delivery systems of finely divided powders, which, thanks to the penetration enhancers, can be successfully administered. These enhancers facilitate the swift disintegration and penetration of the particles through the membrane. This represents a new direction in nasal drug delivery methods. The results of our trials are promising in the development of innovative pharmaceutical products and outline the role of amphiphilic compounds in more efficient utilization and targeted application of active substances. According to our results it can be concluded that this innovative approach not only addresses the common issues associated with liquid nasal formulations but also paves the way for more stable and effective delivery methods. The use of finely divided powders for nasal delivery, enabled by penetration enhancers, represents a major breakthrough in the field, providing a dependable alternative to conventional liquid formulations and ensuring improved therapeutic results.
Graphical Abstract |
doi_str_mv | 10.1208/s12249-024-03000-8 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3130826864</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3130826864</sourcerecordid><originalsourceid>FETCH-LOGICAL-c272t-9fc1fa3dde278adfddea7cd93ac8479b8b8d28fc1b77f47bee5239f75342c5513</originalsourceid><addsrcrecordid>eNp9kEFLwzAUx4Mobk6_gAfp0Us0eWmX5DiGU2EoyDyHNE1cR9vUZD347Y12iichvDx4v_eH90PokpIbCkTcRgqQS0wgx4QRQrA4QlNaMIKlZHD8p5-gsxh3hACjkp2iCZPFHHICUyQ2W5u9-MZm3mWLtt_W6TW1yZa-7f3QVTGru-xJR92k2vleh31tGhvP0YnTTbQXh3-GXld3m-UDXj_fPy4Xa2yAwx5LZ6jTrKoscKErlxrNTSWZNiLnshSlqEAkqOTc5by0tgAmHS9YDqYoKJuh6zG3D_59sHGv2joa2zS6s36IilFGBMzFPE8ojKgJPsZgnepD3erwoShRX8bUaEwlY-rbmBJp6eqQP5StrX5XfhQlgI1ATKPuzQa180Po0s3_xX4CuyR2KA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3130826864</pqid></control><display><type>article</type><title>The Role of Amphiphilic Compounds in Nasal Nanoparticles</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Quoc, Thinh To ; Bíró, Krisztina ; Pető, Ágota ; Kósa, Dóra ; Haimhoffer, Ádám ; Lekli, István ; Pallér, Ádám ; Bak, István ; Gyöngyösi, Alexandra ; Fehér, Pálma ; Bácskay, Ildikó ; Ujhelyi, Zoltán</creator><creatorcontrib>Quoc, Thinh To ; Bíró, Krisztina ; Pető, Ágota ; Kósa, Dóra ; Haimhoffer, Ádám ; Lekli, István ; Pallér, Ádám ; Bak, István ; Gyöngyösi, Alexandra ; Fehér, Pálma ; Bácskay, Ildikó ; Ujhelyi, Zoltán</creatorcontrib><description>Nasal medications hold significant importance and are widely utilized due to their numerous advantageous properties, offering a compelling route for both local and systemic therapeutic effects. Nowadays, the development of nasal particles under 1 micrometer is in the focus of much scientific research. In our experiments, the use of innovative nanotechnology to increase the effectiveness of the active substance was of paramount importance. Our aim was to create solid nanoparticles that enable targeted and effective delivery of the active ingredient into the body. The innovation of this experimental series lies not only in highlighting the importance of amphiphilic compounds in enhancing penetration, but also in the fact that while most nasally administered formulations are in liquid form, our formulation is solid. Liquid formulations frequently suffer from the disadvantage of possible leakage during administration, which can reduce the bioavailability of the active ingredient. In our experiments we created novel drug delivery systems of finely divided powders, which, thanks to the penetration enhancers, can be successfully administered. These enhancers facilitate the swift disintegration and penetration of the particles through the membrane. This represents a new direction in nasal drug delivery methods. The results of our trials are promising in the development of innovative pharmaceutical products and outline the role of amphiphilic compounds in more efficient utilization and targeted application of active substances. According to our results it can be concluded that this innovative approach not only addresses the common issues associated with liquid nasal formulations but also paves the way for more stable and effective delivery methods. The use of finely divided powders for nasal delivery, enabled by penetration enhancers, represents a major breakthrough in the field, providing a dependable alternative to conventional liquid formulations and ensuring improved therapeutic results.
Graphical Abstract</description><identifier>ISSN: 1530-9932</identifier><identifier>EISSN: 1530-9932</identifier><identifier>DOI: 10.1208/s12249-024-03000-8</identifier><identifier>PMID: 39562402</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Administration, Intranasal - methods ; Biochemistry ; Biological Availability ; Biomedical and Life Sciences ; Biomedicine ; Biotechnology ; Chemistry, Pharmaceutical - methods ; Drug Compounding - methods ; Drug Delivery Systems - methods ; Humans ; Nanoparticles - chemistry ; Nasal Mucosa - drug effects ; Nasal Mucosa - metabolism ; Particle Size ; Pharmacology/Toxicology ; Pharmacy ; Powders - chemistry ; Research Article ; Surface-Active Agents - chemistry</subject><ispartof>AAPS PharmSciTech, 2024-11, Vol.25 (8), p.269, Article 269</ispartof><rights>The Author(s) 2024</rights><rights>2024. The Author(s).</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c272t-9fc1fa3dde278adfddea7cd93ac8479b8b8d28fc1b77f47bee5239f75342c5513</cites><orcidid>0000-0001-9724-0614</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1208/s12249-024-03000-8$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1208/s12249-024-03000-8$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>315,781,785,27929,27930,41493,42562,51324</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39562402$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Quoc, Thinh To</creatorcontrib><creatorcontrib>Bíró, Krisztina</creatorcontrib><creatorcontrib>Pető, Ágota</creatorcontrib><creatorcontrib>Kósa, Dóra</creatorcontrib><creatorcontrib>Haimhoffer, Ádám</creatorcontrib><creatorcontrib>Lekli, István</creatorcontrib><creatorcontrib>Pallér, Ádám</creatorcontrib><creatorcontrib>Bak, István</creatorcontrib><creatorcontrib>Gyöngyösi, Alexandra</creatorcontrib><creatorcontrib>Fehér, Pálma</creatorcontrib><creatorcontrib>Bácskay, Ildikó</creatorcontrib><creatorcontrib>Ujhelyi, Zoltán</creatorcontrib><title>The Role of Amphiphilic Compounds in Nasal Nanoparticles</title><title>AAPS PharmSciTech</title><addtitle>AAPS PharmSciTech</addtitle><addtitle>AAPS PharmSciTech</addtitle><description>Nasal medications hold significant importance and are widely utilized due to their numerous advantageous properties, offering a compelling route for both local and systemic therapeutic effects. Nowadays, the development of nasal particles under 1 micrometer is in the focus of much scientific research. In our experiments, the use of innovative nanotechnology to increase the effectiveness of the active substance was of paramount importance. Our aim was to create solid nanoparticles that enable targeted and effective delivery of the active ingredient into the body. The innovation of this experimental series lies not only in highlighting the importance of amphiphilic compounds in enhancing penetration, but also in the fact that while most nasally administered formulations are in liquid form, our formulation is solid. Liquid formulations frequently suffer from the disadvantage of possible leakage during administration, which can reduce the bioavailability of the active ingredient. In our experiments we created novel drug delivery systems of finely divided powders, which, thanks to the penetration enhancers, can be successfully administered. These enhancers facilitate the swift disintegration and penetration of the particles through the membrane. This represents a new direction in nasal drug delivery methods. The results of our trials are promising in the development of innovative pharmaceutical products and outline the role of amphiphilic compounds in more efficient utilization and targeted application of active substances. According to our results it can be concluded that this innovative approach not only addresses the common issues associated with liquid nasal formulations but also paves the way for more stable and effective delivery methods. The use of finely divided powders for nasal delivery, enabled by penetration enhancers, represents a major breakthrough in the field, providing a dependable alternative to conventional liquid formulations and ensuring improved therapeutic results.
Graphical Abstract</description><subject>Administration, Intranasal - methods</subject><subject>Biochemistry</subject><subject>Biological Availability</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Biotechnology</subject><subject>Chemistry, Pharmaceutical - methods</subject><subject>Drug Compounding - methods</subject><subject>Drug Delivery Systems - methods</subject><subject>Humans</subject><subject>Nanoparticles - chemistry</subject><subject>Nasal Mucosa - drug effects</subject><subject>Nasal Mucosa - metabolism</subject><subject>Particle Size</subject><subject>Pharmacology/Toxicology</subject><subject>Pharmacy</subject><subject>Powders - chemistry</subject><subject>Research Article</subject><subject>Surface-Active Agents - chemistry</subject><issn>1530-9932</issn><issn>1530-9932</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><recordid>eNp9kEFLwzAUx4Mobk6_gAfp0Us0eWmX5DiGU2EoyDyHNE1cR9vUZD347Y12iichvDx4v_eH90PokpIbCkTcRgqQS0wgx4QRQrA4QlNaMIKlZHD8p5-gsxh3hACjkp2iCZPFHHICUyQ2W5u9-MZm3mWLtt_W6TW1yZa-7f3QVTGru-xJR92k2vleh31tGhvP0YnTTbQXh3-GXld3m-UDXj_fPy4Xa2yAwx5LZ6jTrKoscKErlxrNTSWZNiLnshSlqEAkqOTc5by0tgAmHS9YDqYoKJuh6zG3D_59sHGv2joa2zS6s36IilFGBMzFPE8ojKgJPsZgnepD3erwoShRX8bUaEwlY-rbmBJp6eqQP5StrX5XfhQlgI1ATKPuzQa180Po0s3_xX4CuyR2KA</recordid><startdate>20241119</startdate><enddate>20241119</enddate><creator>Quoc, Thinh To</creator><creator>Bíró, Krisztina</creator><creator>Pető, Ágota</creator><creator>Kósa, Dóra</creator><creator>Haimhoffer, Ádám</creator><creator>Lekli, István</creator><creator>Pallér, Ádám</creator><creator>Bak, István</creator><creator>Gyöngyösi, Alexandra</creator><creator>Fehér, Pálma</creator><creator>Bácskay, Ildikó</creator><creator>Ujhelyi, Zoltán</creator><general>Springer International Publishing</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-9724-0614</orcidid></search><sort><creationdate>20241119</creationdate><title>The Role of Amphiphilic Compounds in Nasal Nanoparticles</title><author>Quoc, Thinh To ; Bíró, Krisztina ; Pető, Ágota ; Kósa, Dóra ; Haimhoffer, Ádám ; Lekli, István ; Pallér, Ádám ; Bak, István ; Gyöngyösi, Alexandra ; Fehér, Pálma ; Bácskay, Ildikó ; Ujhelyi, Zoltán</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c272t-9fc1fa3dde278adfddea7cd93ac8479b8b8d28fc1b77f47bee5239f75342c5513</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Administration, Intranasal - methods</topic><topic>Biochemistry</topic><topic>Biological Availability</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Biotechnology</topic><topic>Chemistry, Pharmaceutical - methods</topic><topic>Drug Compounding - methods</topic><topic>Drug Delivery Systems - methods</topic><topic>Humans</topic><topic>Nanoparticles - chemistry</topic><topic>Nasal Mucosa - drug effects</topic><topic>Nasal Mucosa - metabolism</topic><topic>Particle Size</topic><topic>Pharmacology/Toxicology</topic><topic>Pharmacy</topic><topic>Powders - chemistry</topic><topic>Research Article</topic><topic>Surface-Active Agents - chemistry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Quoc, Thinh To</creatorcontrib><creatorcontrib>Bíró, Krisztina</creatorcontrib><creatorcontrib>Pető, Ágota</creatorcontrib><creatorcontrib>Kósa, Dóra</creatorcontrib><creatorcontrib>Haimhoffer, Ádám</creatorcontrib><creatorcontrib>Lekli, István</creatorcontrib><creatorcontrib>Pallér, Ádám</creatorcontrib><creatorcontrib>Bak, István</creatorcontrib><creatorcontrib>Gyöngyösi, Alexandra</creatorcontrib><creatorcontrib>Fehér, Pálma</creatorcontrib><creatorcontrib>Bácskay, Ildikó</creatorcontrib><creatorcontrib>Ujhelyi, Zoltán</creatorcontrib><collection>Springer Nature OA/Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>AAPS PharmSciTech</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Quoc, Thinh To</au><au>Bíró, Krisztina</au><au>Pető, Ágota</au><au>Kósa, Dóra</au><au>Haimhoffer, Ádám</au><au>Lekli, István</au><au>Pallér, Ádám</au><au>Bak, István</au><au>Gyöngyösi, Alexandra</au><au>Fehér, Pálma</au><au>Bácskay, Ildikó</au><au>Ujhelyi, Zoltán</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Role of Amphiphilic Compounds in Nasal Nanoparticles</atitle><jtitle>AAPS PharmSciTech</jtitle><stitle>AAPS PharmSciTech</stitle><addtitle>AAPS PharmSciTech</addtitle><date>2024-11-19</date><risdate>2024</risdate><volume>25</volume><issue>8</issue><spage>269</spage><pages>269-</pages><artnum>269</artnum><issn>1530-9932</issn><eissn>1530-9932</eissn><abstract>Nasal medications hold significant importance and are widely utilized due to their numerous advantageous properties, offering a compelling route for both local and systemic therapeutic effects. Nowadays, the development of nasal particles under 1 micrometer is in the focus of much scientific research. In our experiments, the use of innovative nanotechnology to increase the effectiveness of the active substance was of paramount importance. Our aim was to create solid nanoparticles that enable targeted and effective delivery of the active ingredient into the body. The innovation of this experimental series lies not only in highlighting the importance of amphiphilic compounds in enhancing penetration, but also in the fact that while most nasally administered formulations are in liquid form, our formulation is solid. Liquid formulations frequently suffer from the disadvantage of possible leakage during administration, which can reduce the bioavailability of the active ingredient. In our experiments we created novel drug delivery systems of finely divided powders, which, thanks to the penetration enhancers, can be successfully administered. These enhancers facilitate the swift disintegration and penetration of the particles through the membrane. This represents a new direction in nasal drug delivery methods. The results of our trials are promising in the development of innovative pharmaceutical products and outline the role of amphiphilic compounds in more efficient utilization and targeted application of active substances. According to our results it can be concluded that this innovative approach not only addresses the common issues associated with liquid nasal formulations but also paves the way for more stable and effective delivery methods. The use of finely divided powders for nasal delivery, enabled by penetration enhancers, represents a major breakthrough in the field, providing a dependable alternative to conventional liquid formulations and ensuring improved therapeutic results.
Graphical Abstract</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>39562402</pmid><doi>10.1208/s12249-024-03000-8</doi><orcidid>https://orcid.org/0000-0001-9724-0614</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1530-9932 |
ispartof | AAPS PharmSciTech, 2024-11, Vol.25 (8), p.269, Article 269 |
issn | 1530-9932 1530-9932 |
language | eng |
recordid | cdi_proquest_miscellaneous_3130826864 |
source | MEDLINE; SpringerNature Journals |
subjects | Administration, Intranasal - methods Biochemistry Biological Availability Biomedical and Life Sciences Biomedicine Biotechnology Chemistry, Pharmaceutical - methods Drug Compounding - methods Drug Delivery Systems - methods Humans Nanoparticles - chemistry Nasal Mucosa - drug effects Nasal Mucosa - metabolism Particle Size Pharmacology/Toxicology Pharmacy Powders - chemistry Research Article Surface-Active Agents - chemistry |
title | The Role of Amphiphilic Compounds in Nasal Nanoparticles |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-11T13%3A13%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Role%20of%20Amphiphilic%20Compounds%20in%20Nasal%20Nanoparticles&rft.jtitle=AAPS%20PharmSciTech&rft.au=Quoc,%20Thinh%20To&rft.date=2024-11-19&rft.volume=25&rft.issue=8&rft.spage=269&rft.pages=269-&rft.artnum=269&rft.issn=1530-9932&rft.eissn=1530-9932&rft_id=info:doi/10.1208/s12249-024-03000-8&rft_dat=%3Cproquest_cross%3E3130826864%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3130826864&rft_id=info:pmid/39562402&rfr_iscdi=true |